Dean Y. Li - 02 Jan 2025 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Director
Signature
/s/Jonathan Golightly, attorney-in-fact
Issuer symbol
RXRX
Transactions as of
02 Jan 2025
Net transactions value
$0
Form type
4
Filing time
06 Jan 2025, 18:02:41 UTC
Previous filing
04 Oct 2024
Next filing
29 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Award $0 +1,647 +2.2% $0.000000 77,350 02 Jan 2025 Direct F1
holding RXRX Class A Common Stock 1,422,048 02 Jan 2025 By Dean Li and Ruth Li Revocable Trust
holding RXRX Class A Common Stock 1,269,796 02 Jan 2025 By Dean Y. Li GRAT
holding RXRX Class A Common Stock 421,000 02 Jan 2025 By Dean Y. Li 2021 Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.